Ligand Pharmaceuticals reported $22.33M in Stock for its third fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Stock Change
Amgen AMGN:US USD 4.76B 203M
Anika Therapeutics ANIK:US USD 37.24M 1.9M
Baxter International BAX:US USD 2.68B 12M
Bristol Myers Squibb BMY:US USD 2.07B 68M
Clovis Oncology CLVS:US USD 11.42M 1.81M
Eli Lilly And LLY:US USD 3.83B 68.3M
Endo International Ordinary Shares ENDP:US USD 288.91M 1.16M
Gilead Sciences GILD:US USD 2.6B 15M
GlaxoSmithKline GSK:LN GBP 4.66B 5M
Harsco HSC:US USD 80.71M 285K
Heron Therapeutics HRTX:US USD 52.24M 9.08M
Insmed INSM:US USD 66.28M 741K
Intrexon XON:US USD 219K 5K
Karyopharm Therapeutics KPTI:US USD 4.25M 779K
Lannett LCI:US USD 94.12M 1.04M
Ligand Pharmaceuticals LGND:US USD 22.33M 2.45M
Macrogenics MGNX:US USD 1.09M 1.86M
Pacira Pharmaceuticals PCRX:US USD 96.8M 3.79M
Rigel Pharmaceuticals RIGL:US USD 7.12M 898K
Teva Pharmaceutical Industries TEVA:US USD 3.86B 190M
Veracyte VCYT:US USD 13.8M 802K